OBRAZAC ZA PRIJAVU / APPLICATION FORM Predaja sažetka / Abstract text Molimo autore da se pridržavaju uputa i primjera dobro napravljenog sažetka Authors are asked to abide by the instructions and example of a well-constructed summary Dokument nazvati Oral/Poster-Prezime_Autora-Naslov (primjer: Oral-LukicAtypical_presentation_of_sporadic_Creutzfeldt–Jacob_disease), te ga poslati na e-mail kongresa – [email protected] najkasnije do 17. veljače 2017. Document is to be named Oral/Poster-Author_surname-Abstract_title (example: Oral-LukicAtypical_presentation_of_sporadic_Creutzfeldt–Jacob_disease), and to be sent to the congress e-mail – [email protected] no later than February 17th 2017. SAŽETAK / ABSTRACT Naslov sažetka / Abstract title: The Frequency Of Depression And Anxiety At Multiple Sclerosis Patients Autori sažetka / Abstract authors: Armin HADŽIDEDIĆ1, Nadina JOLDIĆ1 , Ilvana RABOTIĆ1, Osman SINANOVIĆ1,2 (Ime-Prezime-Ustanova-Zemlja; Ivan Horvat, University of Rijeka, Faculty of Medicine, Rijeka, Croatia; --- NameSurname-Faculty-Country; Ivana Horvat, University Hospital Center Rijeka, Croatia) 1 Faculty of Medicine, University of Tuzla, 75000 Tuzla, Bosnia and Herzegovina 2 Department of Neurology, University Clinical Center Tuzla, 75000 Tuzla, Bosnia and Herzegovina Kontakt mail / E-mail address: [email protected] Tip izlaganja / Presentation type: (Oralno izlaganje ili poster izlaganje/ Oral presentation or poster presentation) Oral presentation Tekst sažetka / Abstract text: (Do 300 riječi / Up to 300 words) Introduction: Depression is the most common psychiatric disorder which can be found in MS patients at frequency of 50%. Aims: To determine frequency of depression and anxiety in people suffering from MS in relation to age, gender, and duration of the disease. Subjects and Methods: Perspective study included 64 subjects, 32 of them with MS diagnosis and 32 subjects as part of the control group. Inquiry was done in the Association of MS patients from Tuzla Canton, from January 16. to February 03. Becks inventor of anxiety and Becks inventor of depression were used for the research. Statistical Software as Graphpad Prism, ANOVA test and t-test with single and double direction, were used for calculating group differences. Results : 42 women and 22 men (2:1) were included in the research, with equal distribution among both groups of subjects. Average age of people suffering from MS is 46,78 (SD 10,33), and in the control group the average age was 48,19 (SD 11,87);(p>0,5). Average depression in people with MS was (4,9/56.25%, 17,3/9.4%, 23,7/18.75%, 39,4/15.6%), whereas within the control group it was (4,6/90.6%, 16,33/9,4) which has a statistically significant difference (p<0,001). There is a noticeable difference in amount of anxiety between the control group (5,4/68.8%, 12,7/12.5%, 20,3/18,7%) and people with diagnosed MS (8/6.25%, 12,8/15.6%, 20,9/40.6%, 41,8/ 37.5%; p=0,0001), while there is no difference in terms of men and women with MS diagnosis (p>0,05). By comparing the duration of disease with frequency of depression no statistically significant difference is noticeable (p>0,05), while in terms of anxiety it is significant (p=0,01), and the most noticeable is with subjects who are suffering from disease 11-20 years back (34,3/43.75%). Conclusion : Results of this study point to a significant amount of depression and anxiety in MS patients. Ključne riječi / Keywords: (Unesite do 5 ključnih riječi odvojenih zarezom, po uzoru na MeSH / Enter up to 5 keywords) Multiple sclerosis, depression, anxiety, Becks inventory, disease Predajom ovog sažetka izjavljujem da: Sažetak je izvoran rad (do sada nije predstavljan na drugom kongresu, niti objavljen u časopisu/knjizi sažetaka). By submitting this abstract I declare that: Abstract is an original work (never before presented at any congress) and has not been published in other journals/abstract books Svi sažetci će biti pregledani od strane Znanstvenog Odbora. Znanstveni Odbor će biti u kontaktu s autorima (vezano uz eventualne promjene u sažetku), te će kontaktirati autore o prihvaćanju ili odbijanju sažetka (do 15 dana nakon kranjeg roka predaje). All abstracts will be reviewed by the Scientific Committee. Scientific Committee will communicate with authors regarding eventual needed changes, and they will contact the authors to let them know whether their abstract is accepted or rejected (within 15 day after deadline).